Hygeia Healthcare Holdings Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 3/6

Hygeia Healthcare Holdings verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 40.5%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 9%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 28.7%. Die Eigenkapitalrendite von Hygeia Healthcare Holdings beträgt 11.1% und die Nettomargen betragen 15.6%.

Wichtige Informationen

40.5%

Wachstumsrate der Gewinne

35.1%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	11.3%
Wachstumsrate der Einnahmen	28.7%
Eigenkapitalrendite	11.1%
Netto-Marge	15.6%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Aufschlüsselung der Einnahmen und Ausgaben

Wie Hygeia Healthcare Holdings Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

SHSC:6078 Einnahmen, Ausgaben und Erträge (CNY Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
30 Jun 24	4,699	733	473
31 Mar 24	4,388	708	442
31 Dec 23	4,077	683	410
30 Sep 23	3,753	635	375
30 Jun 23	3,429	587	339
31 Mar 23	3,312	532	316
31 Dec 22	3,196	477	293
30 Sep 22	3,053	472	290
30 Jun 22	2,910	468	288
31 Mar 22	2,613	455	257
31 Dec 21	2,315	441	225
30 Sep 21	2,008	403	187
30 Jun 21	1,701	365	149
31 Mar 21	1,551	268	151
31 Dec 20	1,402	170	152
30 Sep 20	1,302	100	159
30 Jun 20	1,203	29	166
31 Mar 20	1,145	35	159
31 Dec 19	1,086	40	152
31 Dec 18	766	3	132
31 Dec 17	596	-46	128

Qualität der Erträge: 6078 hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: 6078Die aktuellen Gewinnspannen (15.6%) sind niedriger als im letzten Jahr (17.1%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 6078In den letzten 5 Jahren sind die Einnahmen von 40.5% pro Jahr erheblich gestiegen.

Beschleunigtes Wachstum: 6078Das Gewinnwachstum des Unternehmens im letzten Jahr (25%) liegt unter seinem 5-Jahres-Durchschnitt (40.5% pro Jahr).

Erträge im Vergleich zur Industrie: 6078 Das Gewinnwachstum im vergangenen Jahr (25%) übertraf das der Branche Healthcare -16.9% .

Eigenkapitalrendite

Hohe Eigenkapitalrendite: 6078Die Eigenkapitalrendite des Unternehmens (11.1%) wird als niedrig angesehen.

Hygeia Healthcare Holdings Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Aufschlüsselung der Einnahmen und Ausgaben

Gewinn- und Umsatzhistorie

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren